AAAAAA

   
Results: 1-9 |
Results: 9
PRECISELY DEFINING HIGH-RISK OPERABLE HEAD AND NECK TUMORS BASED ON RTOG NUMBER-85-03 AND NUMBER-88-24 - TARGETS FOR POSTOPERATIVE RADIOCHEMOTHERAPY
Authors: COOPER JS PAJAK TF FORASTIERE A JACOBS J FU KK ANG KK LARAMORE GE ALSARRAF M
Citation: Js. Cooper et al., PRECISELY DEFINING HIGH-RISK OPERABLE HEAD AND NECK TUMORS BASED ON RTOG NUMBER-85-03 AND NUMBER-88-24 - TARGETS FOR POSTOPERATIVE RADIOCHEMOTHERAPY, Head & neck, 20(7), 1998, pp. 588-594
A PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCN)
Authors: FORASTIERE A GLISSON B MURPHY B FRENETTE G OCONNELL B
Citation: A. Forastiere et al., A PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCN), Annals of oncology, 9, 1998, pp. 361-361
NCCN PRACTICE GUIDELINES FOR HEAD AND NECK-CANCER
Authors: FORASTIERE A GOEPFERT H GOFFINET D HONG KW LARAMORE G MITTAL B PFISTER DG RIDGE J SCHULLER D SHAH J SPENCER S URBA S WOLF G
Citation: A. Forastiere et al., NCCN PRACTICE GUIDELINES FOR HEAD AND NECK-CANCER, Oncology, 12(7A), 1998, pp. 39-147
PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS
Authors: ILSON DH AJANI J BHALLA K FORASTIERE A HUANG Y PATEL P MARTIN L DONEGAN J PAZDUR R REED C KELSEN DP
Citation: Dh. Ilson et al., PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS, Journal of clinical oncology, 16(5), 1998, pp. 1826-1834
PHASE-I AND PHARMACOLOGICAL STUDIES OF TOPOTECAN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION
Authors: OREILLY S ROWINSKY E SLICHENMYER W DONEHOWER RC FORASTIERE A ETTINGER D CHEN TL SARTORIUS S BOWLING K SMITH J BRUBAKER A LUBEJKO B IGNACIO V GROCHOW LB
Citation: S. Oreilly et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF TOPOTECAN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION, Journal of the National Cancer Institute, 88(12), 1996, pp. 817-824
CHEMORADIOTHERAPY FOR ORGAN PRESERVATION IN ORAL AND PHARYNGEAL CARCINOMA
Authors: KOCH WM LEE DJ EISELE DW MILLER D POOLE M CUMMINGS CW FORASTIERE A
Citation: Wm. Koch et al., CHEMORADIOTHERAPY FOR ORGAN PRESERVATION IN ORAL AND PHARYNGEAL CARCINOMA, Archives of otolaryngology, head & neck surgery, 121(9), 1995, pp. 974-980
NEW APPROACHES TO TREATING ESOPHAGEAL CANCER
Authors: OREILLY S FORASTIERE A
Citation: S. Oreilly et A. Forastiere, NEW APPROACHES TO TREATING ESOPHAGEAL CANCER, BMJ. British medical journal, 308(6939), 1994, pp. 1249-1250
TUMOR RESPONSE, TOXICITY, AND SURVIVAL AFTER NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY FOR ADVANCED LARYNGEAL CARCINOMA
Authors: SPAULDING MB FISCHER SG WOLF GT HONG WK URBA S ENDICOTT JW CLOSE L FISHER SR TOOHILL RJ KARP D MILLER D CHEUNG NK WEAVER A HILLEL AD SPAULDING M CHANG BK DOUGHERTY B DECONTI R GAREWAL H FORASTIERE A THORNTON A CALLAWAY E BEALS T GREENBERG H HOLLIMAN D LYMAN G SCHAEFER S COX J MIDDLETON R ASKEW B BRANTLEY A LEOPOLD KA WEINBURG JB LETTINGA JW HAAS CD KAPLAN M BYHARDT RW CORLEW MM CAMPBELL B VAUGHAN C WILLETT B WALSH M URIST M KIM R FAUCETT R PARK Y OHANIAN M KAUFMAN R KISH J EDELSTEIN MB KIM YH SHIRLEY J HIGANO C LARAMORE G MILLER RM CASTILLO M KAPUR S ZURENDA J ISAACS J FIVEASH AE GORDAN M TRULLINGER R SRIDHAR K CHARYULU K BOLLINGER R WANG R KEYES H PETRO A TILSNER T SHIMM D WILSON K FRANCE K CONDON V HATCHER C GLASER L BRANDT R REWIS S COLEMAN W HARDY I CALARESE P BALDWIN P KILLIAN K GARRABRANT C HAYNES V REYES R DAMERON D ASYCUE P ROVELLI P SIMMONS D LEAVELL A MYERS J SKIPPER P ROMERO M BUE B MYERS K TERAN E CANTINELLA B LARAMORE GE DURBIN LM HILLMAN R MCCLATCHEY K GLUCKMAN J WHEELER R MAKUCH RW GILBERT HR FU KK FISHER SG WEBER L CAVELLO D VITEK ME FYE C HENDERSON WG ROWE J DEYKIN D GOLD J HUANG P
Citation: Mb. Spaulding et al., TUMOR RESPONSE, TOXICITY, AND SURVIVAL AFTER NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY FOR ADVANCED LARYNGEAL CARCINOMA, Journal of clinical oncology, 12(8), 1994, pp. 1592-1599
COMPARISON OF INTRAARTERIAL AND INTRAVENOUS-INFUSION OF CISPLATIN FORHEAD AND NECK SQUAMOUS-CELL CARCINOMA IN A MODIFIED RAT MODEL
Authors: MOSES BL CHAN DW HRUBAN RH FORASTIERE A RICHTSMEIER WJ
Citation: Bl. Moses et al., COMPARISON OF INTRAARTERIAL AND INTRAVENOUS-INFUSION OF CISPLATIN FORHEAD AND NECK SQUAMOUS-CELL CARCINOMA IN A MODIFIED RAT MODEL, Archives of otolaryngology, head & neck surgery, 119(6), 1993, pp. 612-617
Risultati: 1-9 |